Chronic pain and treatment-resistant depression — both impact millions of people, both can be debilitating and both can leave people feeling hopeless.

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...

Phase II results for Cybin’s psilocin therapy showed remission rates of 71%, but just eight patients made it to the 12-month ...

Tracey Wade provides an insightful examination of the significance of brief early interventions in the treatment of eating ...

Researchers have developed a mindfulness therapy tailored specifically to appeal to teenagers to help them cope with ...

BUFFALO, N.Y. - University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing ...

Here's how you can get your memory checked this week at no charge, through a series of simple questions at the health ...

During certain seasons of the year, you may notice changes in your energy level, sleep and interest in activities.

"The people who had more fear of recurrence had an increased level of stress," Zvonar said, and stress can be a "huge ...

Fampridine, used for improving walking in multiple sclerosis, may also enhance working memory in individuals with schizophrenia or depression.